Fatima Seerat, Qayoom Seema, Jehangir Majid
Department of Dermatology, Venereology and Leprosy, Sher i Kashmir Institute of Medical Sciences Medical College Srinagar, Jammu and Kashmir, India.
Department of Radiodiagnosis, Government Medical College Srinagar, Jammu and Kashmir, India.
Indian Dermatol Online J. 2025 Apr 23;16(3):402-406. doi: 10.4103/idoj.idoj_510_24. eCollection 2025 May-Jun.
Psoriasis and obesity are known to share many mediators of inflammation with each other such as TNF- and IL-6. Obesity, being a low-grade inflammatory state, is known to affect the disease course, severity, predisposition, and response to therapy in psoriatic patients. Whole-body dual-energy X-ray absorptiometry (DEXA) is a proven method to estimate total, abdominal, and extremity fat mass.
The present study aimed to assess the correlation of the severity of psoriasis with adiposity using regional fat mass DEXA indices.
This was a case-control study involving 153 cases followed through till the completion of the study. A total of 153 age and gender-matched controls were included in the study after ruling out confounding factors. DEXA scans were conducted on both cases and controls; the following indices, including total body fat percentage, android-gynoid ratio, and trunk/limb fat mass ratio, were analyzed.
The total fat percentage, as assessed by DEXA scan, had a mean of 29.13 ± 9.66 (32.12 ± 9.51 for cases and 26.13 ± 8.87 for controls) with a significant value of <0.001. The android/gynoid ratio had a mean of 1.01 ± 0.22 (1.09 ± 0.21 for cases and 0.93 ± 0.21 for controls). Percentage fat trunk/percentage fat limbs (central/peripheral fat) had a mean of 1.05 ± 0.16 (1.08 ± 0.15 for cases and 1.03 ± 0.16 for controls) with a significant value of <0.001. The correlation of DEXA adiposity grading with the severity of psoriasis was found to be significant, with a value of <0.001.
The cross-sectional design restricts assessment to associations rather than causality. Although major confounding factors were ruled out during recruitment, variables such as lifestyle and dietary habits, physical activity levels, and treatment history were not the primary focus and hence not extensively analyzed. The sample size analyses, such as stratification by gender or treatment modalities, may benefit from larger cohorts in future research.
DEXA is a useful indicator of adiposity, with greater total fat percentage, android/gynoid ratio, and trunk/limb fat mass ratio in cases compared to controls and it was positively correlated with the severity of psoriasis in our study.
已知银屑病和肥胖症有许多共同的炎症介质,如肿瘤坏死因子和白细胞介素 - 6。肥胖作为一种低度炎症状态,已知会影响银屑病患者的病程、严重程度、易感性及对治疗的反应。全身双能X线吸收法(DEXA)是一种用于估计全身、腹部和四肢脂肪量的可靠方法。
本研究旨在使用局部脂肪量DEXA指数评估银屑病严重程度与肥胖程度之间的相关性。
这是一项病例对照研究,共纳入153例患者并随访至研究结束。在排除混杂因素后,纳入了153名年龄和性别匹配的对照。对病例组和对照组均进行了DEXA扫描;分析了以下指数,包括全身脂肪百分比、男性化 - 女性化比率和躯干/四肢脂肪量比率。
通过DEXA扫描评估,总脂肪百分比的平均值为29.13±9.66(病例组为32.12±9.51,对照组为26.13±8.87),P值<0.001,差异有统计学意义。男性化/女性化比率的平均值为1.01±0.22(病例组为1.09±0.21,对照组为0.93±0.21)。脂肪躯干百分比/脂肪四肢百分比(中心/外周脂肪)的平均值为1.05±0.16(病例组为1.08±0.15,对照组为1.03±0.16),P值<0.001,差异有统计学意义。发现DEXA肥胖分级与银屑病严重程度之间的相关性具有统计学意义,P值<0.001。
横断面设计限制了对关联性而非因果关系的评估。尽管在招募过程中排除了主要混杂因素,但生活方式和饮食习惯、身体活动水平及治疗史等变量并非主要关注点,因此未进行广泛分析。未来研究中,如按性别或治疗方式进行分层的样本量分析,可能会受益于更大的队列。
DEXA是肥胖程度的一个有用指标,与对照组相比,病例组的总脂肪百分比、男性化/女性化比率和躯干/四肢脂肪量比率更高,且在本研究中与银屑病严重程度呈正相关。